The Prognostic Value of EDRIC and Its Association With Radiation‐Induced Lymphopenia in Patients With Esophageal Cancer Undergoing Radical Radiotherapy: A Single‐Center Chinese Study

Yue Ke, Chen Yang, Yu‐Xing Li, Xiao‐Xiao Liu, Xiao Liu, Jia‐Min Gao, Hong‐Bing Ma · 2026

Read The Prognostic Value of EDRIC and Its Association With Radiation‐Induced Lymphopenia in Patients With Esophageal Cancer Undergoing Radical Radiotherapy: A Single‐Center Chinese Study by Yue Ke, Chen Yang, Yu‐Xing Li, Xiao‐Xiao Liu, Xiao Liu, Jia‐Min Gao, Hong‐Bing Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13399637.txt.

Description

Ke and co-authors test in 2026 whether the radiation dose reaching immune cells predicts survival in esophageal cancer patients on radical radiotherapy. That dose estimate is called EDRIC, and it may also track immune cell loss from treatment. Records for 166 patients at one Chinese center were reviewed, with median follow up of 59 months.

Median EDRIC was 7.23 gray. Five year survival was 33.7 percent below that cut against 19.3 percent above it. Performance status, stage, treatment, EDRIC, and lymphopenia each predicted survival on their own in adjusted models. Higher EDRIC and lymphopenia also predicted worse progression free survival. Treatment and EDRIC tied to severe lymphopenia risk.

Catalog record

CREATORYue Ke, Chen Yang, Yu‐Xing Li, Xiao‐Xiao Liu, Xiao Liu, Jia‐Min Gao, Hong‐Bing Ma
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13399637

Browse the full library · About the Tower of Babel